Boston University researchers, in collaboration with Centers for Therapeutic Innovation (CTI) at Pfizer Inc. (NYSE:PFE), have discovered a novel molecular pathway needed to regulate kidney ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback